Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accident, activitiesght, AgreementSM, ALPINE, AMP, atrial, bank, Bcl, boost, Brazil, Brown, Checkmate, Chinese, CI, Colorado, complyoperating, Connecticut, custodian, cyber, deposit, deprioritized, depth, diverge, Dreyling, effectuated, epidemic, febrile, fibrillation, fifteen, forensic, hacking, Harmonisation, hereunder, hierarchical, HTA, illustrative, Immunopharma, Intelligence, IRA, Jaypirca, lidelalisib, Lyell, malware, marginal, mathematical, maximize, month, myeloblast, MZL, NE, obfuscate, ordinary, outpace, paper, phishing, pirtobrutinib, pluripotent, proportionality, ransomeware, reframing, Regeneron, Rescue, resurgence, riIf, Selinexor, shipment, standing, startup, streamline, Subgroup, Teva, theft, Utah, vedotin, vein, Virginia, watched, withholding, Zhang, zone
Removed:
aberrant, acting, activator, added, analog, analyst, arm, arrange, assay, assured, Bellina, biochemical, bleeding, broker, cancelled, Chair, childhood, CIRLL, cirmtuzumab, cited, concentration, correlation, decreasing, deep, deferring, disaster, discouraging, disrupted, distinguishing, dysregulated, Edwin, Eisai, entitling, Epizyme, ERG, escaping, Evelyn, excessive, exchanged, exercisable, exhaust, fatigue, femur, fever, fragment, Frank, harboring, head, helicase, heterodimer, impeding, Jeffrey, Jordan, killed, leaving, linked, Lombardi, machinery, mandate, manmade, Matthew, maturation, McLinn, Mine, modulation, Mongiello, mRNA, NantCell, Newfront, nonvested, oncogene, overexpressed, overt, pain, participated, pathological, Pharmamar, physiology, placement, poorer, precursor, predominantly, prone, proportional, quartile, rational, rearrangement, remained, remodeling, renew, repair, replication, representing, responding, retrospective, RHA, SARD, SARM, scFv, Schema, son, splicing, structural, studying, succeeded, supplied, suppressor, systemically, Takeda, Tasch, tender, Toretsky, transcriptional, transcriptome, translocation, Trickett, trunk, water, weather, weight, Wendler
Filing tables
Filing exhibits
Related press release
Associated ONCT transcripts
ONCT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Oncternal Therapeutics, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No.333-254985) and Form S-8 (Nos. 333-233288, 333-254581, and 333-263703) of Oncternal Therapeutics, Inc. of our report dated March 9, 2023, relating to the consolidated financial statements, which appears in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/BDO USA, LLP
San Diego, California
March 9, 2023